CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
1,433,313
Share change
-14,900
Total reported value
$19,752,450
Price per share
$13.78
Number of holders
29
Value change
-$309,893
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q4 2013

As of 31 Dec 2013, CANCER GENETICS INC - COM (CGIX) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,433,313 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, Timpani Capital Management LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Sterneck Capital Management, LLC, GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, PERKINS CAPITAL MANAGEMENT INC, SSI INVESTMENT MANAGEMENT INC, TFS CAPITAL LLC, and ROTHSCHILD INVESTMENT CORP /IL. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.